Fig. 1From: A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancerWaterfall plots of best overall percent change from baseline in sum of target lesion diameters. Evaluation was assessed by the central review committee. (evaluable patients only, n = 28). Abbreviations; PR, partial response; SD, stable disease; PD, progressive diseaseBack to article page